These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8531241)

  • 1. Analysis of carcinogenic risk based on mode of drug action.
    Fujii T
    J Toxicol Sci; 1995 Sep; 20(4):459-61. PubMed ID: 8531241
    [No Abstract]   [Full Text] [Related]  

  • 2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenobarbital mouse liver tumors: implications of hepatic tumor promotion for cancer risk assessment.
    McClain RM
    Prog Clin Biol Res; 1995; 391():325-36. PubMed ID: 8532725
    [No Abstract]   [Full Text] [Related]  

  • 4. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats.
    Uehara T; Hirode M; Ono A; Kiyosawa N; Omura K; Shimizu T; Mizukawa Y; Miyagishima T; Nagao T; Urushidani T
    Toxicology; 2008 Aug; 250(1):15-26. PubMed ID: 18619722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CCK-A and CCK-B/gastrin receptors in enterochromaffin-like cell carcinoids of Mastomys natalensis.
    Nilsson O; Kölby L; Wängberg B; Wank SA; Ahlman H
    Ann N Y Acad Sci; 1994 Mar; 713():435-8. PubMed ID: 7910444
    [No Abstract]   [Full Text] [Related]  

  • 7. Nitrapyrin: a scientific advisory group review of the mode of action and carcinogenicity in B6C3F1 mice.
    Yano BL; Hardisty JF; Seely JC; Butterworth BE; McConnell EE; Swenberg JA; Williams GM; Stebbins KE; Golllapudi BB; Eisenbrandt DL
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):53-65. PubMed ID: 18367300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cancer risk estimates are reduced when based on relative risk for common rodent tumors.
    Gaylor DW; Kodell RL; Chen JJ
    Regul Toxicol Pharmacol; 1999 Dec; 30(3):283-4. PubMed ID: 10620477
    [No Abstract]   [Full Text] [Related]  

  • 9. Approaches to the risk assessment of genotoxic carcinogens in food: a critical appraisal.
    O'Brien J; Renwick AG; Constable A; Dybing E; Müller DJ; Schlatter J; Slob W; Tueting W; van Benthem J; Williams GM; Wolfreys A
    Food Chem Toxicol; 2006 Oct; 44(10):1613-35. PubMed ID: 16887251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhalation exposure of carbon tetrachloride promote rat liver carcinogenesis in a medium-term liver bioassay.
    Tsujimura K; Ichinose F; Hara T; Yamasaki K; Otsuka M; Fukushima S
    Toxicol Lett; 2008 Feb; 176(3):207-14. PubMed ID: 18221844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Criteria, rules and procedures adopted by IARC in evaluating risks from different carcinogenic agents for humans].
    IARC
    Vopr Onkol; 2007; 53(6):621-41. PubMed ID: 18416130
    [No Abstract]   [Full Text] [Related]  

  • 12. Thiazopyr and thyroid disruption: case study within the context of the 2006 IPCS Human Relevance Framework for analysis of a cancer mode of action.
    Dellarco VL; McGregor D; Berry SC; Cohen SM; Boobis AR
    Crit Rev Toxicol; 2006; 36(10):793-801. PubMed ID: 17118729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of the uses of rats and mice for assessing carcinogenic risk from chemicals in humans.
    Ward JM
    Asian Pac J Cancer Prev; 2010; 11(1):18. PubMed ID: 20593921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
    Johnson FM
    Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichloroethylene cancer risk: simplified calculation of PBPK-based MCLs for cytotoxic end points.
    Bogen KT; Gold LS
    Regul Toxicol Pharmacol; 1997 Feb; 25(1):26-42. PubMed ID: 9056499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.
    Butterworth BE
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):9-23. PubMed ID: 16530901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.
    Leung HW; Kamendulis LM; Stott WT
    Regul Toxicol Pharmacol; 2005 Dec; 43(3):260-71. PubMed ID: 16188361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of carcinogenicity of daminozide, alone or in combination with its contaminant 1,1-dimethylhydrazine, in a medium-term bioassay.
    Cabral R; Hakoi K; Hoshiya T; Hasegawa R; Ito N
    Teratog Carcinog Mutagen; 1995-1996; 15(6):307-12. PubMed ID: 8732881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do mouse liver tumors predict rat tumors? A study of concordance between tumors induced at different sites in rats and mice.
    Byrd DM; Crouch EA; Wilson R
    Prog Clin Biol Res; 1990; 331():19-41. PubMed ID: 2315341
    [No Abstract]   [Full Text] [Related]  

  • 20. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
    Shirai T; Hirose M; Ito N
    IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.